A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.


Updates from The Motley Fool

Latest updates on Jazz Pharmaceuticals from Fool.com.  The Fool has written over 100 articles on Jazz Pharmaceuticals.
3 Great Stocks on Sale

Sometimes, great stocks can be bought at a discount. Here are three wonderful examples.

3 Stocks to Buy Now in Biotech

If you're looking for ideas in the high-growth biotech sector, these three could be stocks to buy...



Stock Performance

View Interactive JAZZ Charts
Sponsored by

Key Data Points

Primary metrics and data points about Jazz Pharmaceuticals.
Current Price: $135.58
Prev Close: $137.19
Open: $138.03
Bid: $135.45
Ask: $135.74
Day's Range: $134.31 - $138.66
52wk Range: $95.80 - $160.00
Volume: 485,696
Avg Vol 655,838
Market Cap: $8B
P/E (ttm): 23.98
EPS (ttm): $5.72
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Jazz Pharmaceuticals.
CAPS Rating 4 out of 5
 
304 Outperform
66 Underperform
CAPS All Stars
 
70 Outperform
17 Underperform

How do you think Jazz Pharmaceuticals will perform against the market?



You pick for Jazz Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Bruce C. Cozadd, CEO

87% Approve

Based on 17 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Jazz Pharmaceuticals.

A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers